Celecoxib Completed Phase 1 Trials for Breast Cancer

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT00291122An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer